Approval · Notice of Compliance 9260 · 2007
MOBICOX: Notice of Compliance 9260
Issued December 20, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9260
- Date
- December 20, 2007
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph - class labelling for nonsteroidal anti-inflammatory drugs (nsaids)
- Therapeutic class
- Nonsteroidal anti-inflammatory drug (nsaid)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MOBICOX | Not yet assigned | — |